Showing results (481-490 of 615) with videos related to
Sort By:
Pageof 62
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 19, 2019
Comparison of outcomes in infected cardiovascular implantable electronic devices between complete, partial, and failed lead removal: an ESC-EHRA-EORP ELECTRa (European Lead Extraction ConTrolled) registryEyal Nof, Maria Grazia Bongiorni, Angelo Auricchio, et al.International Journal of Cardiology|November 23, 2019
Early mortality after implantable cardioverter defibrillator: Incidence and associated factorsRodrigue Garcia, Serge Boveda, Pascal Defaye, et al.Journal of Cardiovascular Electrophysiology|November 29, 2019
Serratus anterior plane block in subcutaneous implantable cardioverter defibrillator implantation: A case-control analysisMatteo Ziacchi, Giovanni Bisignani, Pietro Palmisano, et al.European Journal of Preventive Cardiology|June 7, 2022
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registryGiuseppe Boriani, Marco Vitolo, Vincenzo L Malavasi, et al.Archives of Cardiovascular Diseases|November 11, 2019
The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and FranceVincent Galand, Cecilia Linde, Nicolas Lellouche, et al.Heart Rhythm|November 24, 2024
Temperature-based rate response in a leadless pacemaker systemMayer Y Rashtian, James E Ip, Derek V Exner, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 14, 2017
Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac deathNelly Amara, Serge Boveda, Pascal Defaye, et al.Biology|January 21, 2022
Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 PandemicMatteo Ziacchi, Leonardo Calò, Antonio D'Onofrio, et al.Heart Rhythm|October 27, 2018
Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantationStefano Viani, Federico Migliore, Gianfranco Tola, et al.Plos One|January 19, 2024
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Igor Diemberger, Violaine Plante-Bordeneuve, et al.Pageof 62